A detailed history of Sol Capital Management CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Sol Capital Management CO holds 1,365 shares of ABBV stock, worth $245,700. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,365
Previous 1,365 -0.0%
Holding current value
$245,700
Previous $234,000 15.38%
% of portfolio
0.03%
Previous 0.03%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 25, 2024

BUY
$137.6 - $154.97 $2,064 - $2,324
15 Added 1.11%
1,365 $212,000
Q3 2023

Oct 19, 2023

SELL
$133.59 - $154.65 $40,077 - $46,395
-300 Reduced 18.18%
1,350 $201,000
Q2 2023

Jul 26, 2023

BUY
$132.51 - $164.9 $22,659 - $28,197
171 Added 11.56%
1,650 $222,000
Q4 2022

Jan 24, 2023

BUY
$138.31 - $165.87 $204,560 - $245,321
1,479 New
1,479 $0
Q1 2022

Apr 18, 2022

SELL
$131.98 - $163.75 $22,700 - $28,165
-172 Reduced 10.42%
1,479 $240,000
Q4 2021

Jan 19, 2022

BUY
$107.43 - $135.93 $177,366 - $224,420
1,651 New
1,651 $224,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sol Capital Management CO Portfolio

Follow Sol Capital Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sol Capital Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Sol Capital Management CO with notifications on news.